cGMP plasmid DNA manufacturing Capabilities

As the global plasmid market continues to grow rapidly, current and projected demand for high quality plasmid continues to be challenged by the availability of global supply. Thermo Fisher’s clinical and commercial capabilities support the manufacture of cGMP plasmid DNA used as a critical raw material to develop and manufacture cell and gene-based therapies including life-saving cancer treatments as well as mRNA vaccines.

Learn more about cGMP plasmid DNA capabilities by downloading our portfolio fact sheet.

Resource Library

Related Sites

Additional Resources